Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Dow, Nasdaq 100 and Nikkei 225 continue their rally​​​​

​​Indices have made further gains, though at a slower pace than in recent sessions, with yesterday’s US data providing more good news on inflation. ​

Source: Bloomberg

​​​Dow returns to 35,000

​The index is back at the 35,000 area, the highs from early September. ​ ​The past three weeks have seen the market make huge gains, with no sign of a reversal yet in view. A close above 35,100 would then open the way to the July highs at 35,650. ​ ​A short-term drop might find support around the 100-day SMA, or further down towards 34,000.

Source: ProRealTime

​Nasdaq 100 hits new 2023 high

​Wednesday’s session briefly saw the index touch the highest level since the beginning of 2022. ​ ​The surge from the 200-day SMA has witnessed a 13% gain for the index, breaking out of the summer descending channel and opening the way to more upside in the direction of the 2022 highs towards 16,600. ​ ​Short-term support might be found around 15,500, the August highs, and then down towards the 100-day SMA.

Source: ProRealTime

​Nikkei 225 reaches trendline resistance

​November’s rally has carried the index back to trendline resistance from the June highs. ​ ​There may be some volatility around this area, which is close to the September lower high, but a close above 33,700 would open the way to the 34,000 highs of June. ​ ​In the short-term, the mid-October highs around 32,500 might provide some support if a pullback develops. ​

Source: ProRealTime

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.